Hip disease of the elderly
Conditions
Interventions
group 1:Ropivacaine concentration 0.5%-10ml·
group 2:Ropivacaine concentration 0.33%-15ml·
group 3:Ropivacaine concentration 0.5%-25ml
Sponsors
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
65 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Receiving hip replacement treatment; (2) Age 65-85 years old; (3) Voluntarily participate in the study and sign the informed consent
Exclusion criteria
Exclusion criteria: (1) cardiopulmonary function level III or above; (2) Patients with central or peripheral nervous system lesions; (3) Liver function grade 2 and above, renal function stage 3 and above; (4) Diabetes or diabetes related neurological complications (5) Abnormal coagulation function or puncture site infection; (6)Patients who were allergic to local anesthetics or refused to enroll in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quadriceps score; | — |
Secondary
| Measure | Time frame |
|---|---|
| QoR40 score;VAS score; the first time of get out of bed ;types and dose of additional pain reliever after surgery;length of patient stay; | — |
Countries
China
Contacts
Public ContactChenpu Wei
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed